Patients with specific skin disorders who are affected by COVID-19: What do experiences say about management strategies? A systematic review.
Dermatol Ther
; 33(6): e13867, 2020 11.
Article
en En
| MEDLINE
| ID: mdl-32558193
Palabras clave
COVID-19; biologic; concomitant; concurrent; corona virus; cutaneous; immunobullous; immunomodulator; immunosuppressive; manifestation; novel human coronavirus (SARS-CoV-2); pemphigoid; pemphigus; psoriasis; psoriatic arthritis; simultaneous; skin; specific skin disease; systematic review; systemic drug
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Enfermedades de la Piel
/
Productos Biológicos
/
Fármacos Dermatológicos
/
COVID-19
/
Inmunosupresores
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
/
Risk_factors_studies
/
Systematic_reviews
Límite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Dermatol Ther
Asunto de la revista:
DERMATOLOGIA
Año:
2020
Tipo del documento:
Article
País de afiliación:
Irán